C22H28N2O4
Neat
384.48
2-Despiperidyl-2-amino Repaglinide; 637301-29-2; Repaglinide (m1); UNII-Z5LJV2074G; Z5LJV2074G; Benzoic acid and 4-(2-(((1S)-1-(2-aminophenyl)-3-methylbutyl)amino)-2-oxoethyl)-2-ethoxy-; RefChem:197749; 4-[2-[[(1S)-1-(2-Aminophenyl)-3-methylbutyl]amino]-2-oxoethyl]-2-ethoxybenzoic Acid; Repaglinide M1 metabolite; 4-(2-{[(1S)-1-(2-Aminophenyl)-3-methylbutyl]amino}-2-oxoethyl)-2-ethoxybenzoic acid; Repaglinide Impurity 35; CHEMBL3527366; DTXSID20652540; 4-[2-[[(1S)-1-(2-aminophenyl)-3-methyl-butyl]amino]-2-oxo-ethyl]-2-ethoxy-benzoic acid; rac 2-Despiperidyl-2-amino Repaglinide; Q27295028; (S)-4-(2-((1-(2-aminophenyl)-3-methylbutyl)amino)-2-oxoethyl)-2-ethoxybenzoic acid; 4-[2-[[(1S)-1-(2-Aminophenyl)-3-methylbutyl]amino]-2-oxoethyl]-2-ethoxybenzoic Acid; 4-[2-[[(1S)-1-(2-Aminophenyl)-3-methylbutyl]amino]-2-oxoethyl]-2-ethoxybenzoic Acid; 4-[2-[[(1S)-1-(2-Aminophenyl)-3-methylbutyl]amino]-2-oxoethyl]-2-ethoxybenzoic acid;Repaglinide M1 metabolite;2-Despiperidyl-2-amino repaglinide
4-[2-[[(1S)-1-(2-aminophenyl)-3-methylbutyl]amino]-2-oxoethyl]-2-ethoxybenzoic acid
InChI=1S/C22H28N2O4/c1-4-28-20-12-15(9-10-17(20)22(26)27)13-21(25)24-19(11-14(2)3)16-7-5-6-8-18(16)23/h5-10,12,14,19H,4,11,13,23H2,1-3H3,(H,24,25)(H,26,27)/t19-/m0/s1